Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2552437 | 0.84 | RAB9A (0.46) | ESR1ESR2KMT2AMEN1L3MBTL1 | |
| SCHEMBL1331344 | 0.81 | RAB9A (0.44) | KMT2AMEN1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL30616301 | 0.80 | RAB9A (0.49) | KMT2AMEN1NPSR1ALDH1A1MAOA | |
| SCHEMBL28462915 | 0.79 | LMNA (0.53) | KMT2ALMNAMEN1MAOBMAPT | |
| SCHEMBL8840922 | 0.78 | RAB9A (0.54) | KMT2AMEN1NPSR1ALDH1A1MAOA | |
| Phenol SCHEMBL25403614 | 0.78 | RAB9A (0.40) | ESR1ESR2KMT2AMEN1ALDH1A1 | |
| SCHEMBL30695173 | 0.77 | RAB9A (0.47) | KMT2AMEN1NPSR1ALDH1A1MAOA | |
| SCHEMBL27971781 | 0.77 | RAB9A (0.45) | ESR1ESR2KMT2AMEN1L3MBTL1 | |
| SCHEMBL20917777 | 0.77 | RAB9A (0.49) | KMT2AMEN1NPSR1ALDH1A1MAOA | |
| SCHEMBL28608606 | 0.77 | MAPT (0.53) | KMT2ALMNAMEN1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130090031-A1 | COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF | FERRANIA TECHNOLOGIES S.P.A. (IT) | 2013-04-11 | — | — | US | disclosed |
| EP-2556113-A1 | COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF | Ferrania Technologies S.p.A. (IT) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556113-A1 | COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF | Ferrania Technologies S.p.A. (IT) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011124522-A1 | COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF | FERRANIA TECHNOLOGIES S.P.A. (IT) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124522-A1 | COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF | FERRANIA TECHNOLOGIES S.P.A. (IT) | 2011-10-13 | — | — | WO | disclosed |
| EP-1819648-B1 | PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER | LG CHEMICAL LTD (KR) | 2009-04-15 | — | — | EP | disclosed |
| US-7422778-B2 | Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer | LG CHEM, LTD. (KR) | 2008-09-09 | — | — | US | disclosed |
| EP-1819648-A4 | PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER | LG CHEMICAL LTD (KR) | 2008-02-13 | — | — | EP | disclosed |
| EP-1819648-A1 | PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER | LG Chemical Ltd. (KR) | 2007-08-22 | — | — | EP | disclosed |
| US-20060121213-A1 | Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer | LG CHEM, LTD. (KR) | 2006-06-08 | — | — | US | disclosed |
| WO-2006059884-A1 | PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER | LG CHEM, LTD. (KR) | 2006-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060121213-A1 | Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer | CRY1, C9, CXCR1 | ESR1 2690/4885ESR2 4729/4885KMT2A 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.